Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $100,824 - $141,713
-2,369 Reduced 4.77%
47,258 $2.67 Million
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $13,805 - $19,978
-429 Reduced 0.86%
49,627 $2.23 Million
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $440,055 - $499,791
-9,956 Reduced 16.59%
50,056 $2.28 Million
Q2 2023

Aug 04, 2023

SELL
$31.86 - $67.26 $12,234 - $25,827
-384 Reduced 0.64%
60,012 $2.6 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $7,134 - $11,658
157 Added 0.26%
60,396 $3.97 Million
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $416,962 - $815,994
10,074 Added 20.08%
60,239 $2.71 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $86,325 - $134,928
-1,193 Reduced 2.32%
50,165 $3.63 Million
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $121,469 - $158,871
-1,393 Reduced 2.64%
51,358 $5.51 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $78,742 - $104,073
836 Added 1.61%
52,751 $5.85 Million
Q4 2021

Feb 11, 2022

SELL
$119.57 - $139.07 $27,142 - $31,568
-227 Reduced 0.44%
51,915 $6.65 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $97,925 - $127,687
-897 Reduced 1.69%
52,142 $6.94 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $102,748 - $118,466
-1,024 Reduced 1.89%
53,039 $5.74 Million
Q1 2021

May 07, 2021

BUY
$101.51 - $125.27 $32,686 - $40,336
322 Added 0.6%
54,063 $5.69 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $39,161 - $48,044
-456 Reduced 0.84%
53,741 $5.59 Million
Q3 2020

Nov 04, 2020

SELL
$72.74 - $92.5 $18.2 Million - $23.1 Million
-249,574 Reduced 82.16%
54,197 $4.64 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $96,232 - $158,396
2,004 Added 0.66%
303,771 $22.3 Million
Q1 2020

May 04, 2020

BUY
$36.95 - $62.95 $717,605 - $1.22 Million
19,421 Added 6.88%
301,767 $15.7 Million
Q4 2019

Feb 05, 2020

BUY
$47.06 - $56.64 $105,320 - $126,760
2,238 Added 0.8%
282,346 $15.9 Million
Q3 2019

Nov 08, 2019

SELL
$47.45 - $58.05 $217,083 - $265,578
-4,575 Reduced 1.61%
280,108 $13.4 Million
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $233,165 - $321,953
-5,939 Reduced 2.04%
284,683 $15.4 Million
Q1 2019

May 06, 2019

SELL
$29.84 - $43.92 $174,355 - $256,624
-5,843 Reduced 1.97%
290,622 $11.8 Million
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $53,939 - $83,458
1,801 Added 0.61%
296,465 $9.24 Million
Q3 2018

Nov 09, 2018

BUY
$40.12 - $45.55 $1.05 Million - $1.19 Million
26,077 Added 9.71%
294,664 $13.4 Million
Q2 2018

Aug 08, 2018

SELL
$38.72 - $42.52 $3.13 Million - $3.44 Million
-80,869 Reduced 23.14%
268,587 $11.3 Million
Q1 2018

May 07, 2018

SELL
$39.4 - $47.39 $504,359 - $606,639
-12,801 Reduced 3.53%
349,456 $14.3 Million
Q4 2017

Feb 09, 2018

BUY
$37.27 - $43.02 $341,095 - $393,719
9,152 Added 2.59%
362,257 $14.9 Million
Q3 2017

Nov 09, 2017

BUY
$33.75 - $41.67 $11.9 Million - $14.7 Million
353,105
353,105 $14.1 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.